Regulatory role of adenosine in insulin secretion from pancreatic β-cells—Action via adenosine A1 receptor and beyond
- 30 November 2014
- journal article
- review article
- Published by Springer Nature in Journal of Physiology and Biochemistry
- Vol. 71 (1) , 133-140
Abstract
Under physiological conditions, insulin secretion from pancreatic β-cells is tightly regulated by different factors, including nutrients, nervous system, and other hormones. Pancreatic β-cells are also influenced by paracrine and autocrine interactions. The results of rodent studies indicate that adenosine is present within pancreatic islets and is implicated in the regulation of insulin secretion; however, effects depend on adenosine and glucose concentrations. Moreover, species differences in adenosine action were found. In rat islets, low adenosine was demonstrated to decrease glucose-induced insulin secretion and this effect is mediated via adenosine A1 receptor. In the presence of high adenosine concentrations, other mechanisms are activated and glucose-induced insulin secretion is increased. It is also well established that suppression of adenosine action increases insulin-secretory response of β-cells to glucose. In mouse islets, low adenosine concentrations do not significantly affect insulin secretion. However, in the presence of higher adenosine concentrations, potentiation of glucose-induced insulin secretion was demonstrated. It is also known that upon stimulation of insulin secretion, both rat and mouse islets release ATP. In rat islets, ATP undergoes extracellular conversion to adenosine. However, mouse islets are unable to convert extracellularly ATP to adenosine and adenosine arises from intracellular ATP degradation.Keywords
This publication has 50 references indexed in Scilit:
- Purinergic signalling and diabetesPurinergic Signalling, 2013
- Islet β cell mass in diabetes and how it relates to function, birth, and deathAnnals of the New York Academy of Sciences, 2013
- Cyclic AMP dynamics in the pancreatic β-cellUpsala Journal of Medical Sciences, 2012
- Purinergic signalling in the pancreas in health and diseaseJournal of Endocrinology, 2012
- Differences between Human and Rodent Pancreatic IsletsJournal of Biological Chemistry, 2011
- Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and BenefitsDiabetes Care, 2010
- Extracellular ATP and zinc are co-secreted with insulin and activate multiple P2X purinergic receptor channels expressed by islet beta-cells to potentiate insulin secretionPurinergic Signalling, 2008
- The mechanisms of alloxan- and streptozotocin-induced diabetesDiabetologia, 2007
- Adenosine receptor activation ameliorates type 1 diabetesThe FASEB Journal, 2007
- Physiological roles for ecto-5’-nucleotidase (CD73)Purinergic Signalling, 2006